Nutrition in Clinical Practice
Nonetheless, the present study demonstrates that therapeutic inertia represents a significant issue, particularly among non-GLP-1RA users
Therefore, it makes sense to aim at a therapy that induces weight loss and reduces hypertension along with a path that could also improve glucose metabolism
Michael's Hospital, Toronto (Canada) 7 More presentations in this session Professor S
While Trizepitide may be slightly more expensive, accessibility has never posed an issue
We are grateful to Andreas Diedenhofen and Vincenzo Giordano from the Sigma-Tau Foundation and Sebastian Chapela from the Departamento de Bioquimica Humana, Facultad de Medicina, Universidad de Buenos Aires, UBA, Argentina, for constructive discussion